THE MODE OF INHIBITION OF HUMAN ERYTHROCYTE MEMBRANE-BOUND ACETYLCHOLINESTERASE BY CISPLATIN IN-VITRO

被引:22
作者
ALJAFARI, AA
KAMAL, MA
DUHAIMAN, AS
机构
[1] Department of Biochemistly, College of Science, King Saud University, Riyadh 11451
来源
JOURNAL OF ENZYME INHIBITION | 1995年 / 8卷 / 04期
关键词
ANTICANCER DRUG; CISPLATIN; ACETYLCHOLINESTERASE; INHIBITION;
D O I
10.3109/14756369509020135
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effect of the well known anticancer drug ''cisplatin'' on the human erythrocyte membrane-bound acetylcholinesterase (AChE) has been investigated. It was found that cisplatin has inhibitory activity against AChE. Cisplatin (0.5-7.0 mM) inhibited AChE activity (27-82%) in a concentration dependent manner. The nature of the inhibition of AChE by cisplatin was complex and involved a partial reversible stage followed by a slow acting irreversible step. The inhibition was independent of a preincubation period up to 90 min while becoming dependent after this period. By diluting the preincubated AChE-cisplatin mixture for different times (0-24 h), the inhibition was partially reversed but again increased progressively with incubation time, ultimately reaching complete inhibition. The effect of increasing substrate concentration had the same behaviour as the dilution effect.
引用
收藏
页码:281 / 289
页数:9
相关论文
共 26 条
[1]   INVESTIGATION OF THE REVERSIBLE INHIBITION OF CAMEL (CAMELUS-DROMEDARIUS) ACETYLCHOLINESTERASE BY TETRACAINE [J].
ALJAFARI, AA .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 1993, 105 (02) :323-327
[3]   SUCCESSFUL COMBINATION CHEMOTHERAPY (CISPLATINUM, VINBLASTINE, AND BLEOMYCIN) IN THE TREATMENT OF MEDULLOBLASTOMA DISSEMINATED BY CEREBROSPINAL-FLUID - CASE-REPORT [J].
ASAI, A ;
MATSUTANI, M ;
KOHNO, T ;
FUJIMAKI, T ;
TAKAKURA, K .
NEUROSURGERY, 1989, 24 (03) :439-443
[4]   THE IMPORTANCE OF DOSE-INTENSITY IN NEOADJUVANT CHEMOTHERAPY OF OSTEOSARCOMA - A RETROSPECTIVE ANALYSIS OF HIGH-DOSE METHOTREXATE, CISPLATINUM AND ADRIAMYCIN USED PREOPERATIVELY [J].
BACCI, G ;
PICCI, P ;
AVELLA, M ;
DALLARI, D ;
FERRARI, S ;
PRASAD, R ;
DISCIOSCIO, M ;
MALAGUTI, C ;
CALDORA, P .
JOURNAL OF CHEMOTHERAPY, 1990, 2 (02) :127-135
[5]   LOWRY ASSAY OF DILUTE PROTEIN SOLUTIONS CONTAINING HIGH-CONCENTRATIONS OF TRITON X-100 [J].
CHANDRARAJAN, J ;
KLEIN, L .
ANALYTICAL BIOCHEMISTRY, 1975, 69 (02) :632-636
[6]  
DANIEL WW, 1974, HLTH SCI, P179
[7]  
DAWON RM, 1990, NEUROSC LETT, V118, P85
[8]   CHEMOTHERAPY IN HEAD AND NECK-CANCER WITH BLEOMYCIN, CISPLATINUM, AND METHOTREXATE [J].
DEITMER, T ;
URBANITZ, D .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1988, 114 (06) :644-646
[9]  
DEPPE G, 1991, European Journal of Gynaecological Oncology, V12, P93
[10]   A NEW AND RAPID COLORIMETRIC DETERMINATION OF ACETYLCHOLINESTERASE ACTIVITY [J].
ELLMAN, GL ;
COURTNEY, KD ;
ANDRES, V ;
FEATHERSTONE, RM .
BIOCHEMICAL PHARMACOLOGY, 1961, 7 (02) :88-&